Seema Bhat

Academic / Other · 2 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Phase 2	2025-05-27
Recruiting	Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma	Phase 2	2023-09-29